$ELVN Cashflow Statement | Understand Stock

$ELVN

$41.49 -$0.03 (0.07%) Close

$ELVN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Non-cash lease expense
Amortization of premiums and discounts on marketable securities, net
Gain on Asset Sale
Write-off of deferred IPO costs
Change in fair value of contingent value right liability
Loss on disposal of property and equipment

Changes in operating assets and liabilities:
Prepaid expenses, other current and long-term assets
Operating lease liabilities
Accounts payable
Accrued expenses and other liabilities
Operating lease assets and liabilities, net

Net cash used in operating activities
Cash flows from investing activities:
Proceeds from maturities and sales of short-term investments
Proceeds from Asset Sale
Purchases of short-term investments
Maturities of marketable securities
Purchases of marketable securities
Receipt of contingent value right milestone
Payment of contingent value right milestone, net of permitted deductions
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from July 2021 Offering, net of underwriting discounts and commissions
Proceeds from ATM offering, net of underwriting discounts and commissions
Proceeds from exercise of stock options
Payment of transaction costs
Payment of deferred offering costs related to the Merger / initial public offering
Payment of deferred offering costs related to the Sales Agreement
Proceeds from issuance of common stock under the Employee Stock Purchase Plan
Proceeds from issuance of common stock and pre-funded warrants in the Public Offering, net of issuance costs
Proceeds from issuance of common stock and Pre-Funded Warrants in the Private Placement, net of issuance costs
Proceeds from issuance of common stock under the Sales Agreement, net of issuance costs
Payment of deferred offering costs related to the establishment of the Sales Agreement
Cash acquired in connection with the reverse recapitalization
Payment of reverse recapitalization transaction costs
Payment of deferred offering costs
Net cash provided by financing activities

Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Supplemental disclosure of cash flow information:
Income taxes paid related to the contingent value right milestone
Lease liabilities obtained in exchange for right-of-use assets
Deferred offering costs related to the Merger included in accounts payable and accrued expenses and other current liabilities
Supplemental disclosure of non-cash investing and financing activities:
Offering costs included in accounts payable and accrued expenses
Right of use asset obtained in exchange for lease liabilities
Unrealized gain (loss) on investments
Realized gain (loss) on investments
Conversion of convertible preferred stock to common stock
Operating lease right-of-use assets obtained in exchange for operating lease liabilities
Receivables from stock option exercises included in prepaid expenses and other current assets

Components of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments